Versant Ventures
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- United States
- Canada
- Europe
Investment stages
- Series B
- Series C
- Growth
- Series A
Industries
- Health Tech
- Biotechnology
- Technology
About
Versant Ventures is a global healthcare-focused venture firm dedicated to translating scientific innovation into sustainable biotech companies, investing across the biotech lifecycle from inception to IPO or M&A.
Versant Ventures is a global healthcare-focused venture firm dedicated to translating scientific innovation into sustainable biotech companies, investing across the biotech lifecycle from inception to IPO or M&A.
Investment Thesis
Versant Ventures is a global healthcare-focused VC that builds and invests in biotech companies, many created in-house via its discovery engines. It supports novel therapeutic innovation from early to growth stages across North America and Europe, with a deep commitment to hands-on scientific company building and translating breakthroughs into market-ready ventures.
Manager's Experience
Versant Ventures, which began as Palladium Venture Capital in 1999, draws on more than a century of combined venture capital experience, augmented by sixty years in pharma and forty-five in biotech, allowing the firm to bridge financial insight with industry-specific know-how.
Team
Brad Bolzon Ph.D. – Chairman
Jerel Davis Ph.D. – Managing Director
Alex Mayweg Ph.D. – Managing Director
Clare Ozawa Ph.D. – Managing Director
Carlo Rizzuto Ph.D. – Managing Director
Tom Woiwode Ph.D. – Managing Director
Markus Enzelberger Ph.D. – Partner
Nigel Sheail – Partner
Peter Emtage Ph.D. – Venture Partner
Richard Glynne Ph.D. – Venture Partner
Portfolio
Alter
Amira
Akero